The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding ... of capillary blood to provide a reliable test result. Samples are typically taken ...
Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support ...
Rosemary Aoko has been buying antiretroviral (ARV) medication for two of her relatives. She found the free medication system too cumbersome, often plagued by stockouts, shortages of preferred drugs, ...
Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...
The test is an enzyme immunoassay similar to ELISA, a platform widely used in ... hindering specific serological diagnosis. To enhance the assay's accuracy in detecting antibodies in the blood ...
The enzyme-linked immunosorbent assay (ELISA) is a sensitive method to quantify or test for the presence of antigen or ligand. Enzyme-linked antibodies (or ligand binding proteins) are used to ...
IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...
Italian duo Maurizio Bormolini and Elisa Caffont have defeated compatriots Gabriel Messner and Jasmin Coratti in the big ...
The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...
Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results